DEA Seeks Chain Of Distribution Information For Pseudoephedrine
This article was originally published in The Tan Sheet
Executive Summary
Importers of ephedrine, pseudoephedrine and phenylpropanolamine will have to provide the Drug Enforcement Administration with information on the foreign chain of distribution from the manufacturer to the importer, under a rule proposed by the agency in the March 31 Federal Register
You may also be interested in...
FDA’s Agenda Slates September For Cough/Cold Proposal, Sunscreen Rule
Meeting deadlines on regulatory agenda actions, such as finalizing OTC monographs, could be a higher priority for FDA under its new management
Senate Passes Bill Enforcing Distributor Compliance With Combat Meth Act
The Senate passed a bill Feb. 11 that requires distributors of pseudoephedrine-containing OTC drugs to sell only to retailers who verify they comply with the Combat Meth Act or who are registered with the DEA
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers